Cargando…

CD14, CD163, and CCR1 are involved in heart and blood communication in ischemic cardiac diseases

OBJECTIVE: Cardiac diseases lead to heart failure (HF), but the progression can take several years. Using blood samples to monitor changes in the heart before clinical symptoms begin may help to improve patient management. METHODS: Microarray data GSE42955 and GSE9128 were used as study datasets and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chengcong, Peng, Hong, Zeng, Yongmei, Dong, Guoqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Pre-Clinical Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521061/ https://www.ncbi.nlm.nih.gov/pubmed/32967511 http://dx.doi.org/10.1177/0300060520951649

Ejemplares similares

CD14+CD16+ and CD14+CD163+ monocyte subpopulations in kidney allograft transplantation
por: Sekerkova, Alena, et al.
Publicado: (2014)

CD163 and CCR7 as markers for macrophage polarization in lung cancer microenvironment
por: KWIECIEŃ, IWONA, et al.
Publicado: (2020)

Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of ‘soluble CD163’ in plasma
por: Etzerodt, Anders, et al.
Publicado: (2017)

Increased Ratio of CD14(++)CD80(+) Cells/CD14(++)CD163(+) Cells in the Infrapatellar Fat Pad of End-Stage Arthropathy Patients
por: Ma, Shuhe, et al.
Publicado: (2021)

The TWEAK/Fn14/CD163 axis—implications for metabolic disease
por: Ratajczak, Wiktoria, et al.
Publicado: (2021)

Relationship Between sCD163 and mCD163 and Their Implication in the Detection and Typing of Leprosy
por: Farag, Azza Gaber Antar, et al.
Publicado: (2020)

CD163 as a Potential Biomarker of Monocyte Activation in Ischemic Stroke Patients
por: Greco, Rosaria, et al.
Publicado: (2021)

CD14(+) monocytes and CD163(+) macrophages correlate with the severity of liver fibrosis in patients with chronic hepatitis C
por: Zhao, Su-Xian, et al.
Publicado: (2020)

Increased Urinary CD163 Levels in Systemic Vasculitis with Renal Involvement
por: Aierken, Xiayire, et al.
Publicado: (2021)

Circulating CD14(+)CD163(+)CD206(+) M2 Monocytes Are Increased in Patients with Early Stage of Idiopathic Membranous Nephropathy
por: Hou, Jie, et al.
Publicado: (2018)

Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection
por: Mascia, Claudia, et al.
Publicado: (2018)

Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study
por: Feng, Lin, et al.
Publicado: (2012)

Soluble CD163 and CD163 Expression on Monocytes Associated with Chronic Hepatitis B Inflammation and HBsAg Loss
por: Xie, Peilin, et al.
Publicado: (2022)

Activated Hepatic Stellate Cells Induce Infiltration and Formation of CD163(+) Macrophages via CCL2/CCR2 Pathway
por: Xi, Sujuan, et al.
Publicado: (2021)

Icariin influences cardiac remodeling following myocardial infarction by regulating the CD147/MMP-9 pathway
por: Shi, Yu, et al.
Publicado: (2018)

Soluble CD 163: A novel biomarker
por: Ahuja, Rajeev B.
Publicado: (2011)

Circulating Soluble CD163: A Potential Predictor for the Functional Outcome of Acute Ischemic Stroke
por: Sun, Houchao, et al.
Publicado: (2021)

CCR2 on CD14(+)CD16(+) monocytes is a biomarker of HIV-associated neurocognitive disorders
por: Williams, Dionna W., et al.
Publicado: (2014)

The Clinical Significance of the CD163+ and CD68+ Macrophages in Patients with Hepatocellular Carcinoma
por: Kong, Ling-Qun, et al.
Publicado: (2013)

In vitro Phenotype Induction of Circulating Monocytes: CD16 and CD163 Analysis
por: Karsulovic, Claudio, et al.
Publicado: (2021)

Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology
por: Gómez-Rial, Jose, et al.
Publicado: (2020)

Targeting the DPP-4-GLP-1 pathway improves exercise tolerance in heart failure patients: a systematic review and meta-analysis
por: Chen, Chengcong, et al.
Publicado: (2019)

Local production of soluble CD163 in the spondyloarthropathic joint
por: Baeten, D, et al.
Publicado: (2003)

Targeting of CD163(+) Macrophages in Inflammatory and Malignant Diseases
por: Skytthe, Maria K., et al.
Publicado: (2020)

CCR9-expressing CD14+HLA-DR(hi) blood monocytes promote intestinal inflammation in IBD
por: Linton, Ludvig, et al.
Publicado: (2011)

Prognostic and predictive value of CD163 expression and the CD163/CD68 expression ratio for response to adjuvant chemotherapy in patients with surgically resected lung squamous cell carcinoma
por: Yanagawa, Naoki, et al.
Publicado: (2023)

CD163 versus CD68 in tumor associated macrophages of classical hodgkin lymphoma
por: Harris, Jonathan A, et al.
Publicado: (2012)

The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma
por: Salmi, Satu, et al.
Publicado: (2019)

Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure
por: Nielsen, Marlene Christina, et al.
Publicado: (2020)

CD47 expression and CD163(+) macrophages correlated with prognosis of pancreatic neuroendocrine tumor
por: Imam, Rami, et al.
Publicado: (2021)

Prophylaxis of decidual CD68(+)/CD163(+) macrophage disbalance in extracorporeal fertilized women
por: Likhachov, Volodymyr, et al.
Publicado: (2023)

Knockdown of CXCL5 inhibits the invasion, metastasis and stemness of bladder cancer lung metastatic cells by downregulating CD44
por: Wang, Weiyi, et al.
Publicado: (2021)

Biochemical and histological changes in the heart of post-partum rats exposed to Natron
por: Saidu, Yusuf, et al.
Publicado: (2018)

Preliminary Study of sCD14 and sCD163 as Predictors of Disease Severity and ICU Admission in COVID-19: Relation to Hematological Parameters, Blood Morphological Changes and Inflammatory Biomarkers
por: Attia, Hend, et al.
Publicado: (2023)

Tissue Levels of CD80, CD163 and CD206 and Their Ratios in Periodontal and Peri-Implant Health and Disease
por: Yilmaz, Mustafa, et al.
Publicado: (2022)

Relevance of TMPRSS2, CD163/CD206, and CD33 in clinical severity stratification of COVID-19
por: Martínez-Diz, Silvia, et al.
Publicado: (2023)

Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors
por: Castley, Alison, et al.
Publicado: (2016)

Drug Trafficking into Macrophages via the Endocytotic Receptor CD163
por: Graversen, Jonas Heilskov, et al.
Publicado: (2015)

Soluble CD163 as a Potential Biomarker in Systemic Sclerosis
por: Frantz, Camelia, et al.
Publicado: (2018)

Soluble CD163 in intracerebral hemorrhage: biomarker for perihematomal edema
por: Roy‐O'Reilly, Meaghan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ia0up8okghp9c9b8vh7r077uil